Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
3
×
ipo
3
×
life sciences
national blog main
3
×
national top stories
new york blog main
san diego blog main
3
×
san diego top stories
san francisco blog main
vc
3
×
venture capital
biogen
biomarin pharmaceutical
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
drug development
indiana blog main
indiana top stories
laura shawver
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
administration
What
bio
ipo
roundup
activity
advance
approvals
becker
billions
biogen
biology
clamped
company
covid
cytokine
delays
developing
dollars
drugs
eaton
economic
enhanced
fast
fda
files
gene
healthcare
impact
including
initial
isn’t
laying
life
lot
medicines
michael
millions
money
moves
new
offering
Language
unset
Current search:
ipo
×
vc
×
" san diego blog main "
×
cancer
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs